Maes, Michael
Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital
108 papers on CoChatORCID 0000-0002-2012-871X
Most cited papers
- Verified
Prolonged Desipramine Treatment Increases the Production of Interleukin-10, an Anti-Inflammatory Cytokine, in C57BL/6 Mice Subjected to the Chronic Mild Stress Model of Depression
Kubera, M., Maes, M., Holan, V., Basta-Kaim, A., Roman, A., & Shani, J. (2001) · Journal of Affective Disorders
Tryptophan and brain disordersStress Responses and Cortisol
Cited by 103
- Verified
Major Differences in Neurooxidative and Neuronitrosative Stress Pathways Between Major Depressive Disorder and Types I and II Bipolar Disorder
Maes, M., Landucci Bonifacio, K., Morelli, N. R., Vargas, H. O., Barbosa, D. S., Carvalho, A. F., & Nunes, S. O. V. (2019) · Molecular Neurobiology
Bipolar Disorder and TreatmentAntioxidant Activity and Oxidative Stress
Cited by 102
- Verified
Curcumin and major depression: A randomised, double-blind, placebo-controlled trial investigating the potential of peripheral biomarkers to predict treatment response and antidepressant mechanisms of change
Lopresti, A. L., Maes, M., Meddens, M. J. M., Maker, G. L., Arnoldussen, E., & Drummond, P. D. (2015) · European Neuropsychopharmacology
Curcumin's Biomedical ApplicationsTreatment of Major Depression
Cited by 99
- Verified
Depression, traumatic stress and interleukin-6
Bob, P., Raboch, J., Maes, M., Susta, M., Pavlat, J., Jasova, D., Vevera, J., Uhrova, J., Benakova, H., & Zima, T. (2010) · Journal of Affective Disorders
Tryptophan and brain disordersStress Responses and Cortisol
Cited by 97
- Verified
Coenzyme Q10 Depletion in Medical and Neuropsychiatric Disorders: Potential Repercussions and Therapeutic Implications
Morris, G., Anderson, G., Berk, M., & Maes, M. (2013) · Molecular Neurobiology
Coenzyme Q10 studies and effectsMitochondrial Function and Pathology
Cited by 96
- Verified
Peripheral immune aberrations in fibromyalgia: A systematic review, meta-analysis and meta-regression
Andrés-Rodríguez, L., Borràs, X., Feliu-Soler, A., Pérez-Aranda, A., Angarita-Osorio, N., Moreno-Peral, P., Montero-Marin, J., García-Campayo, J., Carvalho, A. F., Maes, M., et al. (2020) · Brain Behavior and Immunity
Fibromyalgia and Chronic Fatigue Syndrome ResearchSystemic Sclerosis and Related Diseases
Cited by 95
- Verified
Differences in the immune-inflammatory profiles of unipolar and bipolar depression
Brunoni, A. R., Supasitthumrong, T., Teixeira, A. L., Vieira, E. L., Gattaz, W. F., Benseñor, I. M., Lotufo, P. A., Lafer, B., Berk, M., Carvalho, A. F., et al. (2020) · Journal of Affective Disorders
Tryptophan and brain disordersBipolar Disorder and Treatment
Cited by 94
- Verified
T helper 17 cells may drive neuroprogression in major depressive disorder: Proposal of an integrative model
Slyepchenko, A., Maes, M., Köhler, C. A., Anderson, G., Quevedo, J., Alves, G. S., Berk, M., Fernandes, B. S., & Carvalho, A. F. (2016) · Neuroscience & Biobehavioral Reviews
Tryptophan and brain disordersTreatment of Major Depression
Cited by 89
- Verified
Immune-inflammatory pathways and clinical changes in fibromyalgia patients treated with Mindfulness-Based Stress Reduction (MBSR): A randomized, controlled clinical trial
Andrés-Rodríguez, L., Borràs, X., Feliu-Soler, A., Pérez-Aranda, A., Rozadilla-Sacanell, A., Montero-Marin, J., Maes, M., & Luciano, J. V. (2019) · Brain, Behavior, and Immunity
Fibromyalgia and Chronic Fatigue Syndrome ResearchMindfulness and Compassion Interventions
Cited by 87
- Verified
The role of high-density lipoprotein cholesterol, apolipoprotein A and paraoxonase-1 in the pathophysiology of neuroprogressive disorders
Morris, G., Puri, B. K., Bortolasci, C. C., Carvalho, A., Berk, M., Walder, K., Moreira, E. G., & Maes, M. (2021) · Neuroscience & Biobehavioral Reviews
Paraoxonase enzyme and polymorphismsCholesterol and Lipid Metabolism
Cited by 84
- Verified
Lowered plasma paraoxonase (PON)1 activity is a trait marker of major depression and PON1 Q192R gene polymorphism–smoking interactions differentially predict the odds of major depression and bipolar disorder
Bortolasci, C. C., Vargas, H. O., Souza-Nogueira, A., Barbosa, D. S., Moreira, E. G., Nunes, S. O. V., Berk, M., Dodd, S., & Maes, M. (2014) · Journal of Affective Disorders
Paraoxonase enzyme and polymorphismsTryptophan and brain disorders
Cited by 83
- Verified
Cytokine Profile in Patients with Progressive Multiple Sclerosis and Its Association with Disease Progression and Disability
Kallaur, A. P., Oliveira, S. R., Simão, A. N. C., Alfieri, D. F., Flauzino, T., Lopes, J., de Carvalho Jennings Pereira, W. L., de Meleck Proença, C., Borelli, S. D., Kaimen-Maciel, D. R., et al. (2017) · Molecular Neurobiology
Multiple Sclerosis Research StudiesPsoriasis: Treatment and Pathogenesis
Cited by 75
- Verified
N-acetylcysteine for therapy-resistant tobacco use disorder: a pilot study
Prado, E., Maes, M., Piccoli, L. G., Baracat, M., Barbosa, D. S., Franco, O., Dodd, S., Berk, M., & Vargas Nunes, S. O. (2015) · Redox Report
Smoking Behavior and CessationSubstance Abuse Treatment and Outcomes
Cited by 69
- Verified
Associations of serum cytokine receptor levels with melancholia, staging of illness, depressive and manic phases, and severity of depression in bipolar disorder.
Siwek, M., Sowa-Kućma, M., Styczeń, K., Misztak, P., Nowak, R. J., Szewczyk, B., Dudek, D., Rybakowski, J. K., Nowak, G., & Maes, M. (2017) · Molecular Neurobiology
Bipolar Disorder and TreatmentTryptophan and brain disorders
Cited by 65
- Verified
Bias in emerging biomarkers for bipolar disorder
Carvalho, A. F., Köhler, C. A., Fernandes, B. S., Quevedo, J., Miskowiak, K. W., Brunoni, A. R., Machado-Vieira, R., Maes, M., Vieta, E., & Berk, M. (2016) · Psychological Medicine
Bipolar Disorder and TreatmentMeta-analysis and systematic reviews
Cited by 63
- Verified
A further exploration of the relationships between immune parameters and the HPA-axis activity in depressed patients
Maes, M., Bosmans, E., Suy, E., Minner, B., & Raus, J. (1991) · Psychological Medicine
Stress Responses and CortisolTryptophan and brain disorders
Cited by 62
- Verified
Protocol and rationale-the efficacy of minocycline as an adjunctive treatment for major depressive disorder: a double blind, randomised, placebo controlled trial
Dean, O. M., Maes, M., Ashton, M., Berk, L., Kanchanatawan, B., Sughondhabirom, A., Tangwongchai, S., Ng, C., Dowling, N., Malhi, G. S., et al. (2014) · Clinical Psychopharmacology and Neuroscience
Treatment of Major DepressionTryptophan and brain disorders
Cited by 58
- Verified
Inflammatory versus anti-inflammatory profiles in major depressive disorders-the role of IL-17, IL-21, IL-23, IL-35 and Foxp3
Gałecka, M., Bliźniewska-Kowalska, K., Orzechowska, A., Szemraj, J., Maes, M., Berk, M., Su, K.-P., & Gałecki, P. (2021) · Journal of Personalized Medicine
Tryptophan and brain disordersTreatment of Major Depression
Cited by 57
- Verified
IgM-mediated autoimmune responses directed against anchorage epitopes are greater in Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) than in major depression
Maes, M., Mihaylova, I., Kubera, M., Leunis, J.-C., Twisk, F. N. M., & Geffard, M. (2012) · Metabolic Brain Disease
Fibromyalgia and Chronic Fatigue Syndrome ResearchLong-Term Effects of COVID-19
Cited by 52
- Verified
Comparison of major depression diagnostic classification probability using the SCID, CIDI, and MINI diagnostic interviews among women in pregnancy or postpartum: An individual participant data meta‐analysis
Levis, B., McMillan, D., Sun, Y., He, C., Rice, D. B., Krishnan, A., Wu, Y., Azar, M., Sanchez, T. A., Chiovitti, M. J., et al. (2019) · International Journal of Methods in Psychiatric Research
Maternal Mental Health During Pregnancy and PostpartumAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Cited by 49
- Verified
IL-10 Is Associated with Increased Mu-Opioid Receptor Levels in Major Depressive Disorder
Al-Fadhel, S. Z., Al-Hakeim, H. K., Al-Dujaili, A. H., & Maes, M. (2019) · European Psychiatry
Tryptophan and brain disordersStress Responses and Cortisol
Cited by 44
- Verified
Impact of single nucleotide polymorphisms of base excision repair genes on DNA damage and efficiency of DNA repair in recurrent depression disorder
Czarny, P., Kwiatkowski, D., Toma, M., Kubiak, J., Sliwinska, A., Talarowska, M., Szemraj, J., Maes, M., Galecki, P., & Sliwinski, T. (2017) · Molecular Neurobiology
DNA Repair MechanismsGenetic Associations and Epidemiology
Cited by 43
- Verified
An immune gate of depression—Early neuroimmune development in the formation of the underlying depressive disorder
Kowalczyk, M., Szemraj, J., Bliźniewska, K., Maes, M., Berk, M., Su, K.-P., & Gałecki, P. (2019) · Pharmacological Reports
Tryptophan and brain disordersStress Responses and Cortisol
Cited by 38
- Verified
Autobiographical memory dysfunctions in depressive disorders
Talarowska, M., Berk, M., Maes, M., & Gałecki, P. (2016) · Psychiatry and Clinical Neurosciences
Identity, Memory, and TherapyMemory Processes and Influences
Cited by 38
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free